ndd Medical Technologies’ Mobile Pulmonary Function Test Targets Pulmonary Fibrosis

Isaura Santos avatar

by Isaura Santos |

Share this article:

Share article via email

nndndd Medical Technologies, a top firm in innovative mobile pulmonary function testing (PFT) that utilizes precise ultrasound mechanisms, recently announced that the company’s EasyOne Pro® was used at a free clinic event held by the San Antonio Pulmonary Fibrosis Support Group. The patients targeted by the clinic were those with interstitial lung disease (ILD) or pulmonary fibrosis (PF), as well as those suspected of having one of these diseases.

“The EasyOne Pro’s portability and ability to accurately perform mobile PFTs in under 30 minutes make it the perfect device for this type of clinic. It allows us to use the patients’ time more efficiently, better understand their illness, and improve assessment of their condition. It’s easy to operate and allows us to provide prompt and accurate assessment of patients’ lung function,” said Anoop Nambiar, who is the Medical Director of the San Antonio Pulmonary Fibrosis Support Group and Director of the University of Texas Health Science Center at San Antonio (UTHSCSA) Center for Interstitial Lung Disease in a press release.

PF is a condition characterized by scar tissue formation around the lungs’ air sacs, which results in hardening and breathing difficulties since it is more difficult for oxygen to pass into the bloodstream. Damage to lungs and loss of lung function are irreversible. Idiopathic pulmonary fibrosis, or IPF, is a variety of PF and its causes remain unknown; the disease worsens over time and is associated with a worse prognosis than several common cancers such as those of the breast, prostate and colon. Only 50 percent of the patients that suffer from IPF are alive 3 to 5 years after the time of their diagnosis. Recent studies say that IPF may have a prevalence in the United States of 1 out of every 200 adults over the age of 65.

[adrotate group=”3″]

“For many in our community, these clinics are the only medical care they receive, so it is vital that we continue such services and raise awareness about the invisible disease that is PF. I want to thank everyone who made this clinic possible— from the UTHSCSA respiratory therapy students who volunteered their time to ndd Medical Technologies for donating equipment,” noted Dorothy Delarosa, the Director and Founder of the San Antonio Pulmonary Fibrosis Association who is also a PF patient.